Top Markets
#1 ADO Protocol ADO Protocol +329.39%
#2 GoPlus Security GoPlus Security +52.29%
#3 Nockchain Nockchain +48.47%
#4 The Black Bull The Black Bull +39.67%
#5 Starpower Starpower +34.78%
#6 Tutorial Tutorial +32.63%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.47%
#8 Fake World Assets Fake World Assets +27.22%
#9 GAIB AID GAIB AID +24.67%
#10 Verus Coin Verus Coin +20.20%
Coin of the day
ADO Protocol ADO Protocol
設定
言語
日本
通貨
USD
テーマ
China Regenerative Medicine International Limited China Regenerative Medicine International Limited

China Regenerative Medicine International Limited

8158
株式のランク #32814
China Regenerative Medicine International Limited operates as an investment... China Regenerative Medicine International Limited operates as an investment holding entity, focusing on the development and distribution of a diverse portfolio of healthcare products and associated services. The company provides extensive health management solutions, covering health condition assessments, detoxification programs, fostering internal bodily balance, nourishing vital organs, and enhancing the immune system. Additionally, its beauty offerings encompass non-surgical medical aesthetics, essential dermatological care, anti-aging skin remedies, hair revitalization, skin firming treatments, localized body contouring, and intimate restoration services. Established in 1995, the organization was previously known as China Bio-Med Regeneration Technology Limited until its rebranding to China Regenerative Medicine International Limited in March 2015. Its headquarters are situated in Tsim Sha Tsui, Hong Kong.
株価
$0.02967889
最終同期: 2026-08-12
時価総額
$9.03M
変化（1日）
0.00%
変化（1年）
-72.68%
国
HK
取引 China Regenerative Medicine International Limited (8158)

カテゴリー

Healthcare
China Regenerative Medicine International Limited（8158）の収益
Aug 2026 時点の収益 TTM: 0
China Regenerative Medicine International Limited の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
China Regenerative Medicine International Limited の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE